Expertise in
5
conditions

Bruno Francois

CHU Dupuytren, 2 Avenue Martin Luther King, 
Limoges, FR 
Expertise in
5
conditions
CHU Dupuytren, 2 Avenue Martin Luther King, 
Limoges, FR 
OverviewLocationsClinical Research

Overview

Bruno Francois practices in Limoges, France. Mr. Francois is highly rated in 5 conditions, according to our data. His top areas of expertise are Pneumonia, Sepsis, Hospital-Acquired Pneumonia, and Severe Acute Respiratory Syndrome (SARS).

His clinical research consists of co-authoring 154 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

CHU Dupuytren, 2 Avenue Martin Luther King, Limoges, 87042, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion: a Randomized Controlled Multi-center Trial
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion: a Randomized Controlled Multi-center Trial
Enrollment Status: Completed
Publish Date: November 21, 2025
Intervention Type: Drug
Study Drug: Dobutamine
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled, Single-dose Study to Evaluate the Efficacy and Safety of Suvratoxumab in Mechanically Ventilated Adults and Adolescents for the Prevention of Nosocomial Pneumonia
A Phase 3, Randomized, Double-blind, Placebo-controlled, Single-dose Study to Evaluate the Efficacy and Safety of Suvratoxumab in Mechanically Ventilated Adults and Adolescents for the Prevention of Nosocomial Pneumonia
Enrollment Status: Terminated
Publish Date: March 24, 2025
Intervention Type: Biological, Drug
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
Enrollment Status: Completed
Publish Date: September 23, 2024
Intervention Type: Biological, Drug
Study Drugs: Otilimab, Standard of Care
Study Phase: Phase 2
Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia
Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia
Enrollment Status: Completed
Publish Date: January 10, 2023
Intervention Type: Drug
Study Drug: Hydrocortisone
Study Phase: Phase 3
A Phase Ib/IIa, Randomised, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess the Safety and Efficacy of Expanded Cx611 Allogeneic Adipose-derived Stem Cells (eASCs) for the Intravenous Treatment of Adult Patients With Severe Community-acquired Bacterial Pneumonia and Admitted to the Intensive Care Unit
A Phase Ib/IIa, Randomised, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess the Safety and Efficacy of Expanded Cx611 Allogeneic Adipose-derived Stem Cells (eASCs) for the Intravenous Treatment of Adult Patients With Severe Community-acquired Bacterial Pneumonia and Admitted to the Intensive Care Unit
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Biological, Other
Study Drug: Cx611
Study Phase: Phase 1/Phase 2
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Enrollment Status: Completed
Publish Date: March 23, 2020
Intervention Type: Other, Biological
Study Phase: Phase 2
Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock
Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock
Enrollment Status: Completed
Publish Date: October 24, 2019
Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain Death
Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain Death
Enrollment Status: Completed
Publish Date: October 24, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
TRIAGE: TRIage of Sepsis At emerGency dEpartment
TRIAGE: TRIage of Sepsis At emerGency dEpartment
Enrollment Status: Completed
Publish Date: April 24, 2018
Cardiopulmonary Effects of Bronchoalveolar Wash on Patients With Acute Respiratory Distress Syndrome
Cardiopulmonary Effects of Bronchoalveolar Wash on Patients With Acute Respiratory Distress Syndrome
Enrollment Status: Terminated
Publish Date: March 29, 2018
Intervention Type: Procedure
Study Phase: Not Applicable
View 9 Less Clinical Trials

154 Total Publications

A mechanism-based prognostic enrichment strategy for the development of the TREM-1 inhibitor nangibotide in septic shock.
A mechanism-based prognostic enrichment strategy for the development of the TREM-1 inhibitor nangibotide in septic shock.
Journal: Intensive care medicine
Published: April 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Francois's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile